BlackRock’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9M Buy
5,790,408
+2,603,316
+82% +$15.7M ﹤0.01% 3047
2026
Q1
$19.6M Buy
3,187,092
+482,086
+18% +$4M ﹤0.01% 3095
2025
Q4
$28.2M Buy
2,705,006
+2,324
+0.1% +$23.3K ﹤0.01% 2884
2025
Q3
$24.3M Sell
2,702,682
-304,428
-10% -$2.67M ﹤0.01% 2971
2025
Q2
$39.1M Sell
3,007,110
-68,727
-2% -$1.03M ﹤0.01% 2601
2025
Q1
$77.7M Buy
3,075,837
+104,187
+4% +$3.1M ﹤0.01% 2141
2024
Q4
$102M Buy
2,971,650
+184,342
+7% +$8.31M ﹤0.01% 2069
2024
Q3
$138M Buy
2,787,308
+386,844
+16% +$19.8M ﹤0.01% 1893
2024
Q2
$144M Buy
2,400,464
+290,905
+14% +$16.6M ﹤0.01% 1809
2024
Q1
$109M Buy
2,109,559
+33,089
+2% +$1.62M ﹤0.01% 2009
2023
Q4
$83.7M Buy
2,076,470
+223,381
+12% +$6.55M ﹤0.01% 2181
2023
Q3
$51.7M Buy
1,853,089
+223,161
+14% +$6.65M ﹤0.01% 2377
2023
Q2
$46.9M Buy
1,629,928
+382,119
+31% +$8.5M ﹤0.01% 2524
2023
Q1
$20.8M Buy
1,247,809
+222,907
+22% +$3.15M ﹤0.01% 2952
2022
Q4
$13M Buy
1,024,902
+40,036
+4% +$487K ﹤0.01% 3266
2022
Q3
$11.8M Buy
984,866
+42,326
+4% +$581K ﹤0.01% 3337
2022
Q2
$13.3M Buy
942,540
+206,951
+28% +$2.73M ﹤0.01% 3346
2022
Q1
$9.11M Buy
735,589
+340,091
+86% +$4.08M ﹤0.01% 3630
2021
Q4
$4.45M Buy
395,498
+45,747
+13% +$550K ﹤0.01% 4042
2021
Q3
$4.43M Buy
+349,751
New +$4.81M ﹤0.01% 4005

Other funds holding RXST

BlackRock's RXST Position: Q2 2026 in Review

BlackRock increased its RxSight (RXST) stake by 82% in Q2 2026, buying an estimated $15.7M and bringing the position to 5,790,408 shares worth $27.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

BlackRock first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $144M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • BlackRock held 5,790,408 shares of RxSight worth $27.9M as of Q2 2026.
  • BlackRock bought 2,603,316 RxSight shares in Q2 2026, an estimated $15.7M.
  • RxSight made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3047 holding.
  • BlackRock first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's RxSight position peaked at $144M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.